A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

Name: A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
Published: 2009
License: Public Domain

Astellas Pharma Inc · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

non-hodgkin's lymphoma, relapsed, cd20-positive, ym155, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

Related documents